Clinical Trial: A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Solid Tumor
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Brief Summary:
The purpose of this dose escalation study is to evaluate the safety profile of escalating doses and dose schedules of NXP900.
Read more